Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 4, Issue 2, 2006, Pages 148-153

  Norton, Jeffrey A ^a   Fang, Tony D ^a   Jensen, Robert T ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Endocrine neoplasia type 1; Gastrinoma; Insulinoma; Pancreatic endocrine tumor

Indexed keywords

PROTON PUMP INHIBITOR;

ARTICLE; CANCER SURGERY; GASTRINOMA; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; INSULINOMA; MORBIDITY; MULTIPLE ENDOCRINE NEOPLASIA; PANCREATICODUODENECTOMY; PEPTIC ULCER; PROGNOSIS; STOMACH ACID SECRETION; SURGICAL MORTALITY; SURVIVAL; TREATMENT INDICATION; ZOLLINGER ELLISON SYNDROME; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; PANCREAS TUMOR; PATHOLOGY; REVIEW; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

BIOPSY, NEEDLE; FEMALE; GASTRINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INSULINOMA; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33646854364     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2006.0015     Document Type: Article

References (56)

1. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-407.
2. Schussheim DH, Skarulis MC, Agarwal SK, et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 2001;12:173-178.
3. Gibril F, Schumann M, Pace A, Jensen RT. Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1 (MEN1): a prospective NIH study of 107 patients and comparison with 1009 patients from the literature. Medicine 2004;83:43-83.
4. Norton JA, Jensen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 2004;240:757-773.
5. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990;322:723-727.
6. Thompson NW, Vinik AI, Eckhauser FE. Microgas trinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome. Ann Surg 1989;209:396-404.
7. vanHeerden JA, Smith SL, Miller LJ. Management of the Zullinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Surgery 1986;100:971-977.
8. Deveney CW, Deveney KS, Stark D, et al. Resection of gastrinomas. Ann Surg 1983;198:546-553.
9. Jensen RT, Gardner JD, Raufman JP, et al. Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med 1983;98:59-75.
10. Malagelada JR, Edis AJ, Adson MA, et al. Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 1983;84:1524-1532.
11. Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implications. Am J Surg 1984;147:25-31.
12. Thompson JC, Lewis BG, Wiener I, et al. The role of surgery in the Zollinger-Ellison syndrome. Ann Surg 1983;197:594-607.
13. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-644.
14. Fishbeyn VA, Norton JA, Benya RV, et al. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med 1993;119:199-206.
15. MacFarlane MP, Fraker DL, Alexander HR, et al. A prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia-type 1. Surgery 1995;118:973-980.
16. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann Surg 1992;215:8-18.
17. Howard TJ, Zinner MJ, Stabile RE, et al. Gastrinoma excision for cure. A prospective analysis. Ann Surg 1990;211:9-14.
18. Norton JA, Jensen RT. Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surg Oncol 2003;12:145-151.
19. Norton JA. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 1994;31:77-156.
20. Stabile BE, Passaro Jr E. Benign and malignant gastrinoma. Am J Surg 1985;49:144-150.
21. Stadil F. Treatment of gastrinomas with pancreaticoduodencctomy. In: Mignon M, Jensen RT, eds. Endocrine tumors of the pancreas: recent advances in research and management. Series: Frontiers in Gastrointestinal Research. Basel, Switzerland: S. Karger, 1995:333-341.
22. Delcore R, Friesen SR. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome. Surgery 1992;112:1016-1022.
23. Imamura M, Kanda M, Takahashi K, et al. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg 1992;16:703-709.
24. Ruszniewski P, Malka D. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 2000;62:79-83.
25. Ruszniewski P, Rougier P, Roche A, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993;71:2624-2630.
26. Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg 2001;234:495-506.
27. Cadiot G, Vuagnat A, Doukhan I, et al. Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Gastroenterology 1999;116:286-293.
28. Wells Jr SA. Surgery for the Zollinger-Ellison syndrome. N Engl J Med 1999;341:689-690.
29. Skogseid B, Oherg K, Eriksson B, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg 1996;20:872-877.
30. Grama D, Eriksson B, Martensson H, et al. Clinical characteristics, treatment and survival in patients with pancreatic rumors causing hormonal syndromes. World J Surg 1992;16:632-639.
31. Thompson NW. Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1. Surg Oncol Clin N Am 1998;7:881-891.
32. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86:5658-5671.
33. Lowney JK, Frisella MM, Lairmore TC, et al. Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size. Surgery 1999;125:1043-1049.
34. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998;243:495-500.
35. Jensen RT. Zollinger-Ellison syndrome. In: Doherty GM, Skogseid B, eds. Surgical Endocrinology: Clinical Syndromes. Philadelphia: Lippincott Williams & Wilkins; 2001:291-344.
36. Thompson NW. Multiple endocrine neoplasia type I. Surgical therapy. Cancer Treat Res 1997;89:407-419.
37. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 2000;128:958-966.
38. Weher HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995;108:1637-1649.
39. Jensen RT. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Intern Med 1998;243:477-488.
40. Doherty GM, Olson JA, Frisella MM, et al. Lethality of multiple endocrine neoplasia type I. World J Surg 1998;22:581-587.
41. Shepherd JJ. The natural history of multiple endocrine neoplasia type I. Highly uncommon or highly unrecognized. Arch Surg 1991;126:935-952.
42. Shepherd JJ, Challis DR, Davies PF, et al. Multiple endocrine neoplasm, type 1: gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases. Arch Surg 1993;128:1133-1142.
43. Gibril F, Chen Y-J, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003;88:1066-1081.
44. Bordi C, Falchetti A, Azzoni C, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 1997;21:1075-1082.
45. Dean PG, vanHeerden JA, Farley DR, et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death? World J Surg 2000;24:1437-1441.
46. Wilkinson S, Teh BT, Davey KR, et al. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 1993;128:683-690.
47. Gibril F, Venzon DJ, Ojeaburu JV, et al. Prospective study of the natural history of gastrinoma in patients with MEN 1: Definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 2001;86:5282-5293.
48. Yu F, Venzon D, Serrano J, et al. Propsective study of the clinical course, prognostic factors and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 1999;17:615-630.
49. Fraker DL, Norton JA, Alexander HR, et al. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994;220:320-330.
50. Doherty GM. Multiple endocrine neoplasia type 1. J Surg Oncol 2005;89:143-148.
51. Sheppard BC, Norton JA, Doppman JL, et al. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery 1989;106:1108-1118.
52. Marx SJ, Agarwal SK, Kester MB, et al. Multiple endocrine neoplasia type 1: clinical and genetic features of hereditary neoplasias. Recent Prog Horm Res 1999;54:397-438.
53. Rasbach DA, van Heerden JA, Telander RL, et al. Surgical management of hyperinsulinism in the multiple endocrine neoplasia type 1 syndrome. Arch Surg 1985;120:584-589.
54. van Heerden JA, Edis AJ, Service FJ, et al. The surgical aspects of insulinomas. Ann Surg 1979;18:677-682.
55. Gumbs AA, Moore PS, Falconi M, et al. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002;81:45-53.
56. Hiramoto JS, Feldstein VA, Laberge JM, Norton JA. Inrraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001;136:1020-1025.